Skip to content
Upperton logo
  • Solutions
    • By route of deliveryOral, Nasal, Pulmonary & Parenteral
          • By route of delivery

          • OralTablets, capsules, powders and granules
          • NasalSprays, suspensions and dry powders
          • Nose-to-brain / CNS DeliveryDirect nasal routes for CNS programmes
          • Pulmonary & InhalationDry powder and inhaled dosage forms
          • Parenteral, Aseptic & Fill-FinishSterile vials and aseptic processing
          • Not sure where to start?

            Tell us the molecule and the stage.

            Every enquiry goes to a formulation scientist.

            Start a project →
    • By stage & servicePre-clinical to market
          • By stage & service

          • Formulation DevelopmentBioavailability, Solubility, Target Profile
          • Analytical Development & ValidationMethod development, transfer and stability
          • Phase I - II Clinical SupplyGMP batches for early clinical studies
          • Process Scale-Up for Phase IIIBench to commercial scale transfer
          • Regulatory Affairs SupportCMC documentation and submissions
          • Not sure where to start?

            Tell us the molecule and the stage.

            Every enquiry goes to a formulation scientist.

            Start a project →
    • Platforms & TechnologyOur proprietary toolkit
          • Platforms & Technology

          • Spray DryingOur core enabling technology
          • UpperNose TMNasal delivery platform
          • PulmoCraft TMEngineered particles for inhalation
          • UpperSolv TMSolubility enhancement
          • Spray-Dried BiologicsProteins, peptides and monoclonal antibodies
          • Not sure where to start?

            Tell us the molecule and the stage.

            Every enquiry goes to a formulation scientist.

            Start a project →
    • Complex & Controlled MoleculesSpecialist potency handling
          • Complex & Controlled Molecules

          • High-Potency APIs & ContainmentContained handling in dedicated suites
          • Controlled Substances ManufacturingLicensed facility for scheduled substances
          • Psychedelics & Novel CNSFormulation and supply for emerging CNS work
          • Not sure where to start?

            Tell us the molecule and the stage.

            Every enquiry goes to a formulation scientist.

            Start a project →
  • Choose Upperton
        • A CDMO partner that steps up where others turn away

          Expertise across oral, nasal, pulmonary and parenteral dosage forms

        • Selecting Your CDMO PartnerWhy choose us
        • Quality & ComplianceMHRA and FDA inspected, GMP throughout
        • Our Project Management ApproachOne team, from start to finish
        • Case Studies & Track RecordProgrammes we have taken to market
        • Case studies

          Rapid tech transfer to clinical manufacture

          Read how we reached clinical dosing within three months, through strong communication, flexibility and responsiveness.

          Read the case study →
  • About us
        • About Upperton

        • FacilitiesTrent Gateway, Nottingham
        • Our PeopleLeadership, board and subject matter experts
        • EventsWhere to meet us
        • Company OverviewWho we are and what we do
        • CareersWorking at Upperton
        • ESGEnvironmental, social and governance
        • Awards & AchievementsAward-winning CDMO
        • Working here

          Scientists, not a form queue.

          Open roles across formulation, analytical and operations.

          See open roles →
  • Resources
        • One library. Filter it your way.

          Search across everything, then narrow by route, platform, service or stage.

        • Popular filters

        • Spray drying
        • Inhalation
        • Biologics
        • Solubility
        • Phase I-II
        • Sterile fill-finish
        • Browse by type

        • Articles & InsightsTechnical articles from our scientists
        • Whitepapers & InfosheetsIn-depth technical documents
        • BrochuresCapability and facility overviews
        • Webinars & Scientific PostersRecorded sessions and conference posters
        • Media / Press KitLogos, imagery and press contacts
        • FAQCommon questions on process and supply
        • Featured whitepaper

          Spray drying biologics: an alternative to freeze drying.

          Dr Richard Johnson, Chief Scientific Officer.

          Download →
  • Contact
        • One enquiry form. Tell us the stage and it routes itself.

          No separate proposal request, no separate discovery call booking.

        • What stage is your project?

        • Early / exploratory
        • Pre-clinical
        • Phase I-II
        • Phase III+
        • Commercial
        • Get in touch

          Call +44 (0) 115 855 7050
          Email contact@upperton.com
          Visit Trent Gateway, Technology Drive, Beeston, Nottingham, NG9 1LA

        • Start a project

          Send us the brief and we will reply within one working day.

          Answered by a scientist who works on your route.

          Open the form →

Contact Us

Upperton is a UK-based CDMO delivering drug product development, formulation, clinical manufacturing, and regulatory support for biotech and pharmaceutical companies worldwide.

Get in Touch

Trent Gateway, Technology Drive,
Beeston, Nottingham, NG9 1LA, UK

+44 (0) 115 855 7050

contact@upperton.com

Integrated CDMO services

  • Solutions
    • By route of delivery
      • Oral
      • Nasal
      • Nose-to-brain / CNS Delivery
      • Pulmonary & Inhalation
      • Parenteral, Aseptic & Fill-Finish
    • By stage & service
      • Formulation Development
      • Analytical Development & Validation
      • Phase I – II Clinical Supply
      • Process Scale-Up for Phase III
      • Regulatory Affairs Support
    • Platforms & Technology
      • Spray Drying
      • UpperNose TM
      • PulmoCraft TM
      • UpperSolv TM
      • Spray-Dried Biologics
    • Complex & Controlled Molecules
      • High-Potency APIs & Containment
      • Controlled Substances Manufacturing
      • Psychedelics & Novel CNS
  • Choose Upperton
    • Selecting Your CDMO Partner
    • Quality & Compliance
    • Our Project Management Approach
    • Case Studies & Track Record
  • About us
    • Facilities
    • Our People
    • Events
    • Company Overview
    • Careers
    • ESG
    • Awards & Achievements
  • Resources
    • Articles & Insights
    • Whitepapers & Infosheets
    • Brochures
    • Webinars & Scientific Posters
    • Media / Press Kit
    • FAQ
    • Spray drying
    • Inhalation
    • Biologics
    • Solubility
    • Phase I-II
    • Sterile fill-finish
  • Contact
    • Early / exploratory
    • Pre-clinical
    • Phase I-II
    • Phase III+
    • Commercial
  • Solutions
    • By route of delivery
      • Oral
      • Nasal
      • Nose-to-brain / CNS Delivery
      • Pulmonary & Inhalation
      • Parenteral, Aseptic & Fill-Finish
    • By stage & service
      • Formulation Development
      • Analytical Development & Validation
      • Phase I – II Clinical Supply
      • Process Scale-Up for Phase III
      • Regulatory Affairs Support
    • Platforms & Technology
      • Spray Drying
      • UpperNose TM
      • PulmoCraft TM
      • UpperSolv TM
      • Spray-Dried Biologics
    • Complex & Controlled Molecules
      • High-Potency APIs & Containment
      • Controlled Substances Manufacturing
      • Psychedelics & Novel CNS
  • Choose Upperton
    • Selecting Your CDMO Partner
    • Quality & Compliance
    • Our Project Management Approach
    • Case Studies & Track Record
  • About us
    • Facilities
    • Our People
    • Events
    • Company Overview
    • Careers
    • ESG
    • Awards & Achievements
  • Resources
    • Articles & Insights
    • Whitepapers & Infosheets
    • Brochures
    • Webinars & Scientific Posters
    • Media / Press Kit
    • FAQ
    • Spray drying
    • Inhalation
    • Biologics
    • Solubility
    • Phase I-II
    • Sterile fill-finish
  • Contact
    • Early / exploratory
    • Pre-clinical
    • Phase I-II
    • Phase III+
    • Commercial

By Development Stage

  • Pre-clinical
  • Phase 1 to Phase 2
  • Phase 3 – Commercial
  • Pre-clinical
  • Phase 1 to Phase 2
  • Phase 3 – Commercial

Development Platforms

  • PulmoCraft
  • UpperNose
  • UpperSolv
  • PulmoCraft
  • UpperNose
  • UpperSolv

Route of delivery

  • Oral
  • Nasal
  • Pulmonary
  • Parenteral
  • Oral
  • Nasal
  • Pulmonary
  • Parenteral

About Us

  • About
  • Our Facilities
  • Our History
  • Awards and Achievements
  • Executive Management Team
  • Board of Directors
  • Careers
  • About
  • Our Facilities
  • Our History
  • Awards and Achievements
  • Executive Management Team
  • Board of Directors
  • Careers

Our Approach

  • Project Management
  • Project Management

Events

  • Events & Seminars
  • Events & Seminars

Policies

  • News
  • Insights
  • Webinars
  • Whitepapers
  • Scientific Posters
  • Frequently Asked Questions
  • News
  • Insights
  • Webinars
  • Whitepapers
  • Scientific Posters
  • Frequently Asked Questions

Our Approach

  • Privacy Policy
  • ESG Code of Conduct
  • Criminal Offence Policy
  • Whistleblower Policy
  • Privacy Policy
  • ESG Code of Conduct
  • Criminal Offence Policy
  • Whistleblower Policy